GlassScriptPhysician profile
John Bevan Millett
NPI 1386696664
$12,808.09
in general payments reported to CMS, 2019-2025
55 companies · $1,899 in 2025
The $1,899 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,560 · 2020: $1,281 · 2021: $2,057 · 2022: $1,870 · 2023: $1,919 · 2024: $2,223 · 2025: $1,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,968 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,967.90 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,590.76 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,314.48 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $1,186.43 | 2019-2025 | |
| Novo Nordisk INC | $1,161.30 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,048.36 | 2019-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Lilly USA, LLC | $1,030.94 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $796.45 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $605.10 | 2019-2025 | Evenity, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $388.27 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Teva Pharmaceuticals USA, INC. | $365.17 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $310.29 | 2019-2025 | Trintellix |
| Astellas Pharma US INC | $292.83 | 2019-2024 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $236.29 | 2022-2025 | Rexulti, Abilify Asimtufii |
| Bayer Healthcare Pharmaceuticals INC. | $220.09 | 2021-2025 | |
| Exact Sciences Corporation | $210.38 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Millett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.